Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ugt2a3 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2A3 mRNA] | CTD | PMID:31150632 | Ugt2a3 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Ugt2a3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2A3 mRNA | CTD | PMID:36331819 | Ugt2a3 | Rat | (2,4,5-trichlorophenoxy)acetic acid | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | 2,4,5-Trichlorophenoxyacetic Acid results in increased expression of UGT2A3 mRNA | CTD | PMID:18579281 | Ugt2a3 | Rat | 1,2-dichloroethane | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of UGT2A3 mRNA | CTD | PMID:28189721|PMID:28960355 | Ugt2a3 | Rat | 17beta-estradiol | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Estradiol results in decreased expression of UGT2A3 mRNA | CTD | PMID:39298647 | Ugt2a3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UGT2A3 mRNA | CTD | PMID:21724226 | Ugt2a3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of UGT2A3 mRNA | CTD | PMID:32109520 | Ugt2a3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Ugt2a3 (Mus musculus) | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of UGT2A3 mRNA] | CTD | PMID:22496397 | Ugt2a3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UGT2A3 mRNA | CTD | PMID:19144771|PMID:19770486|PMID:22496397 | Ugt2a3 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of UGT2A3 mRNA | CTD | PMID:38648751 | Ugt2a3 | Rat | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Ugt2a3 (Mus musculus) | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of UGT2A3 mRNA] | CTD | PMID:19467301 | Ugt2a3 | Rat | 3,4-dihydroxybenzoic acid | multiple interactions | EXP | | 6480464 | protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of UGT2A3 mRNA] | CTD | PMID:37105472 | Ugt2a3 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of UGT2A3 mRNA | CTD | PMID:39298647 | Ugt2a3 | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of UGT2A3 mRNA | CTD | PMID:31881176 | Ugt2a3 | Rat | aflatoxin B1 | decreases methylation | ISO | UGT2A3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of UGT2A3 gene | CTD | PMID:27153756 | Ugt2a3 | Rat | arotinoid acid | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... | CTD | PMID:34480604 | Ugt2a3 | Rat | arsane | affects methylation | ISO | UGT2A3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of UGT2A3 gene | CTD | PMID:25304211 | Ugt2a3 | Rat | arsenic atom | affects methylation | ISO | UGT2A3 (Homo sapiens) | 6480464 | Arsenic affects the methylation of UGT2A3 gene | CTD | PMID:25304211 | Ugt2a3 | Rat | arsenous acid | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of UGT2A3 mRNA | CTD | PMID:39716349 | Ugt2a3 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of UGT2A3 gene | CTD | PMID:28931070 | Ugt2a3 | Rat | benzo[a]pyrene | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of UGT2A3 mRNA | CTD | PMID:20127859 | Ugt2a3 | Rat | benzo[a]pyrene | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of UGT2A3 mRNA | CTD | PMID:21632981|PMID:32234424|PMID:33411230 | Ugt2a3 | Rat | beta-naphthoflavone | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | beta-Naphthoflavone results in decreased expression of UGT2A3 mRNA | CTD | PMID:19144771 | Ugt2a3 | Rat | beta-naphthoflavone | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of UGT2A3 protein | CTD | PMID:39638853 | Ugt2a3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UGT2A3 mRNA | CTD | PMID:25181051 | Ugt2a3 | Rat | bisphenol A | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of UGT2A3 mRNA | CTD | PMID:33221593 | Ugt2a3 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | cyanidin-3-O-beta-glucopyranoside inhibits the reaction [bisphenol A results in increased expression of UGT2A3 mRNA]; protocatechuic acid more ... | CTD | PMID:37105472 | Ugt2a3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of UGT2A3 mRNA | CTD | PMID:37105472 | Ugt2a3 | Rat | bisphenol A | affects expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | bisphenol A affects the expression of UGT2A3 mRNA | CTD | PMID:30903817 | Ugt2a3 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UGT2A3 more ... | CTD | PMID:39012411 | Ugt2a3 | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UGT2A3 more ... | CTD | PMID:39012411 | Ugt2a3 | Rat | cannabidiol | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Cannabidiol results in increased expression of UGT2A3 mRNA | CTD | PMID:31052254 | Ugt2a3 | Rat | carbon nanotube | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of UGT2A3 mRNA | CTD | PMID:25620056 | Ugt2a3 | Rat | CGP 52608 | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to UGT2A3 gene] | CTD | PMID:28238834 | Ugt2a3 | Rat | chenodeoxycholic acid | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Chenodeoxycholic Acid results in decreased expression of UGT2A3 mRNA | CTD | PMID:27174168 | Ugt2a3 | Rat | chenodeoxycholic acid | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:34589561 | Ugt2a3 | Rat | CHIR 99021 | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... | CTD | PMID:34480604 | Ugt2a3 | Rat | chlorohydrocarbon | multiple interactions | EXP | | 6480464 | [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of more ... | CTD | PMID:30744511 | Ugt2a3 | Rat | cisplatin | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of UGT2A3 mRNA | CTD | PMID:27392435 | Ugt2a3 | Rat | clofibrate | multiple interactions | ISO | Ugt2a3 (Mus musculus) | 6480464 | [Clofibrate co-treated with PPARA protein mutant form] results in increased expression of UGT2A3 mRNA | CTD | PMID:22496397 | Ugt2a3 | Rat | copper(II) sulfate | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Copper Sulfate results in increased expression of UGT2A3 mRNA | CTD | PMID:18579281 | Ugt2a3 | Rat | cortisol | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... | CTD | PMID:34480604 | Ugt2a3 | Rat | cyclosporin A | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of UGT2A3 mRNA | CTD | PMID:20106945|PMID:25562108|PMID:27989131 | Ugt2a3 | Rat | deoxycholic acid | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:34589561 | Ugt2a3 | Rat | deoxynivalenol | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of UGT2A3 protein | CTD | PMID:39638853 | Ugt2a3 | Rat | dexamethasone | affects expression | EXP | | 6480464 | Dexamethasone affects the expression of UGT2A3 mRNA | CTD | PMID:15102944 | Ugt2a3 | Rat | Diallyl sulfide | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | allyl sulfide results in decreased expression of UGT2A3 mRNA | CTD | PMID:19144771 | Ugt2a3 | Rat | diarsenic trioxide | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of UGT2A3 mRNA | CTD | PMID:39716349 | Ugt2a3 | Rat | dicrotophos | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of UGT2A3 mRNA | CTD | PMID:28302478 | Ugt2a3 | Rat | dimethyl sulfoxide | increases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Dimethyl Sulfoxide results in increased expression of UGT2A3 mRNA | CTD | PMID:39709020 | Ugt2a3 | Rat | ethanol | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Ethanol results in decreased expression of UGT2A3 mRNA | CTD | PMID:31059573 | Ugt2a3 | Rat | fenthion | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Fenthion results in increased expression of UGT2A3 mRNA | CTD | PMID:34813904 | Ugt2a3 | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of UGT2A3 mRNA | CTD | PMID:23962444 | Ugt2a3 | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:34589561 | Ugt2a3 | Rat | glycocholic acid | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:34589561 | Ugt2a3 | Rat | glycodeoxycholic acid | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:34589561 | Ugt2a3 | Rat | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2A3 mRNA | CTD | PMID:22129741 | Ugt2a3 | Rat | L-ascorbic acid | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with more ... | CTD | PMID:34480604 | Ugt2a3 | Rat | L-ascorbic acid 2-phosphate | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA more ... | CTD | PMID:34480604 | Ugt2a3 | Rat | metformin | increases expression | EXP | | 6480464 | Metformin results in increased expression of UGT2A3 mRNA | CTD | PMID:31324951 | Ugt2a3 | Rat | methidathion | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | methidathion results in increased expression of UGT2A3 mRNA | CTD | PMID:34813904 | Ugt2a3 | Rat | methyl methanesulfonate | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of UGT2A3 mRNA | CTD | PMID:23649840 | Ugt2a3 | Rat | methylmercury chloride | multiple interactions | EXP | | 6480464 | [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of more ... | CTD | PMID:30744511 | Ugt2a3 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2A3 mRNA | CTD | PMID:22129741 | Ugt2a3 | Rat | okadaic acid | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of UGT2A3 mRNA | CTD | PMID:38832940 | Ugt2a3 | Rat | oltipraz | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | oltipraz results in decreased expression of UGT2A3 mRNA | CTD | PMID:22496397 | Ugt2a3 | Rat | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of UGT2A3 mRNA | CTD | PMID:23665939 | Ugt2a3 | Rat | oxybenzone | decreases expression | EXP | | 6480464 | oxybenzone results in decreased expression of UGT2A3 mRNA | CTD | PMID:30316929 | Ugt2a3 | Rat | paracetamol | affects expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of UGT2A3 mRNA | CTD | PMID:17562736 | Ugt2a3 | Rat | paracetamol | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... | CTD | PMID:34589561 | Ugt2a3 | Rat | paracetamol | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of UGT2A3 mRNA | CTD | PMID:29067470 | Ugt2a3 | Rat | paracetamol | multiple interactions | ISO | Ugt2a3 (Mus musculus) | 6480464 | PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of UGT2A3 mRNA] | CTD | PMID:29246445 | Ugt2a3 | Rat | paracetamol | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of UGT2A3 mRNA | CTD | PMID:29246445 | Ugt2a3 | Rat | perfluorononanoic acid | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of UGT2A3 mRNA | CTD | PMID:32588087 | Ugt2a3 | Rat | perfluorooctane-1-sulfonic acid | affects expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid affects the expression of UGT2A3 mRNA | CTD | PMID:19429403 | Ugt2a3 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ugt2a3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2A3 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Ugt2a3 | Rat | perfluorooctanoic acid | affects expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | perfluorooctanoic acid affects the expression of UGT2A3 mRNA | CTD | PMID:18281256|PMID:19429403 | Ugt2a3 | Rat | phenformin | increases expression | EXP | | 6480464 | Phenformin results in increased expression of UGT2A3 mRNA | CTD | PMID:31324951 | Ugt2a3 | Rat | phenobarbital | affects expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Phenobarbital affects the expression of UGT2A3 mRNA | CTD | PMID:19136022 | Ugt2a3 | Rat | pirinixic acid | affects expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | pirinixic acid affects the expression of UGT2A3 mRNA | CTD | PMID:19136022 | Ugt2a3 | Rat | pirinixic acid | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of UGT2A3 mRNA | CTD | PMID:23811191 | Ugt2a3 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of UGT2A3 mRNA | CTD | PMID:19144771|PMID:27413110|PMID:28903501 | Ugt2a3 | Rat | quercetin | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of UGT2A3 mRNA | CTD | PMID:21632981 | Ugt2a3 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of UGT2A3 mRNA | CTD | PMID:28374803 | Ugt2a3 | Rat | SB 431542 | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in more ... | CTD | PMID:34480604 | Ugt2a3 | Rat | senecionine | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | senecionine results in decreased expression of UGT2A3 mRNA | CTD | PMID:26100227 | Ugt2a3 | Rat | sodium arsenite | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of UGT2A3 mRNA | CTD | PMID:33933676 | Ugt2a3 | Rat | tetrachloromethane | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of UGT2A3 mRNA | CTD | PMID:27339419|PMID:31919559 | Ugt2a3 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2A3 mRNA] | CTD | PMID:31150632 | Ugt2a3 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of UGT2A3 mRNA | CTD | PMID:31150632 | Ugt2a3 | Rat | tetracycline | increases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Tetracycline results in increased expression of UGT2A3 mRNA | CTD | PMID:16917069 | Ugt2a3 | Rat | Torularhodin | multiple interactions | ISO | Ugt2a3 (Mus musculus) | 6480464 | torularhodin inhibits the reaction [Dietary Fats results in decreased expression of UGT2A3 protein] | CTD | PMID:36234935 | Ugt2a3 | Rat | trichloroethene | decreases expression | ISO | Ugt2a3 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of UGT2A3 mRNA | CTD | PMID:29353386 | Ugt2a3 | Rat | valproic acid | decreases methylation | ISO | UGT2A3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of UGT2A3 gene | CTD | PMID:29154799 | Ugt2a3 | Rat | valproic acid | decreases expression | ISO | UGT2A3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of UGT2A3 mRNA | CTD | PMID:29154799 | Ugt2a3 | Rat | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of UGT2A3 gene | CTD | PMID:31682807 | Ugt2a3 | Rat | XAV939 | multiple interactions | ISO | UGT2A3 (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA more ... | CTD | PMID:34480604 | | |||||||||||||||||||






















